vTv Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
vTv Therapeutics Inc. (VTVT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum of 89.03% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum · last filed 2026-03-10
- vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2025 was 89.03%, a 8.06% decline from fiscal 2024.
- vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2024 was 96.84%, a 19.97% decline from fiscal 2023.
- vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2023 was 121.01%, a 1.93% increase from fiscal 2022.
- vTv Therapeutics Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate, minimum for fiscal 2022 was 118.72%, a 0.03% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum 12 month |
|---|---|
| 2025-12-31 | 89.03% 10-K · filed 2026-03-10 |
| 2024-12-31 | 96.84% 10-K · filed 2026-03-10 |
| 2023-12-31 | 121.01% 10-K · filed 2026-03-10 |
| 2022-12-31 | 118.72% 10-K · filed 2025-03-20 |
| 2021-12-31 | 118.75% 10-K · filed 2024-03-13 |